Company
Lumen
Biologic Drugs Reimagined
Also known as Lumen Bioscience, Lumen Bioscience, Inc.
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Seattle, WA, United States
- Founded
- 2017
- Employees
- >100 FTEs, including 40+ with MDs, PhDs, and other post-graduate degreesSource (opens in a new tab)
- Legal name
- Lumen Bioscience, Inc.
- lumen.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Lumen unlocks the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. Our goal is to transform the way such drugs are developed, what they cost, and who has access to them.
Funding snapshot
- Total raised
- $30MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Series C, $30M2025-10-08
Funding rounds
- Series C
- $30M2025-10-08, Company stated
- Round, 2025
- 2025-04-01
- Round, 2024
- 2024-11-19
- Round, 2023
- 2023-09-15
- Round, 2022
- 2022-06-29
- Round, 2019
- 2019-11-12
Loading relationship preview